The Contemporary Role of Photodynamic Therapy in the Treatment of Pachychoroid Diseases
Recent advances in retinal imaging technology have improved our understanding in the pathogenesis and evolvement of various chorioretinal diseases. Central serous chorioretinopathy and polypoidal choroidal vasculopathy are now recognized to belong to the same spectrum of disorders known as pachychoroid diseases.
Lawrence P. L. Iu +7 more
wiley +1 more source
Clinical Characteristics of Neovascular Age‐Related Macular Degeneration without Typical Drusen
Purpose. To evaluate the clinical characteristics of neovascular age‐related macular degeneration (nAMD) patients without typical drusen. Methods. We retrospectively studied 165 eyes in 165 patients with treatment‐naïve nAMD, including typical AMD and polypoidal choroidal vasculopathy (PCV).
Hiroyuki Kamao +6 more
wiley +1 more source
Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation
Central serous chorioretinopathy (CSCR) is a macular disease characterized by serous retinal detachment commonly involving the macular region. CSCR has a wide spectrum of clinical presentations. Although a significant proportion of CSCR cases are self‐limiting, patients can suffer from persistent or recurrent disease, sometimes complicated with ...
Mary Ho +6 more
wiley +1 more source
Pachychoroid Spectrum Disease: Comparison of Patients with Central Serous Chorioretinopathy Complicated with Pachychoroid Neovasculopathy. [PDF]
Purpose: This study aimed to determine the incidence and visual outcomes of pachychoroid neovasculopathy (PNV) in patients initially diagnosed with central serous chorioretinopathy (CSC).Methods: In this study, 144 patients aged 20 to 55 years with treatment-naive chronic CSC, defined as the persistence of subretinal fluid (SRF) for ≥6 months, were ...
Jung H +7 more
europepmc +3 more sources
OCT Biomarkers in Neovascular Age‐Related Macular Degeneration: A Narrative Review
Age‐related macular degeneration (AMD) is the leading cause of legal blindness in elderly people. Neovascular AMD (nAMD) is responsible for the majority of cases of severe visual loss in eyes with AMD. Optical coherence tomography (OCT) is the most widely used technology for the diagnosis and follow‐up of nAMD patients, which is widely used to study ...
Cristian Metrangolo +10 more
wiley +1 more source
Pachychoroid neovasculopathy in a male patient: a case report [PDF]
Pachychoroid neovasculopathy is a form of type 1 (subretinal pigment epithelium) neovascularization characterized by the involvement of dilated choroidal vessels in areas of increased choroidal thickness. This disease was originally described in three white female patients.
Miguel Hage, Amaro +1 more
openaire +5 more sources
Wide-Field Choroidal Thickness Analysis after Half-Fluence Photodynamic Therapy Combined with Intravitreal Aflibercept Injection in Pachychoroid Neovasculopathy [PDF]
Keijiro Ishikawa +2 more
exaly +2 more sources
Prevalence of focal lamina cribrosa defects in eyes with pachychoroid disease spectrum [PDF]
AIM: To determine the prevalence of focal lamina cribrosa (LC) defect among patients with pachychoroid disease spectrum (PDS) in the absence of peripapillary retinoschisis. METHODS: This retrospective, cross-sectional study comprised of 180 patients with
Hae Min Kang +4 more
doaj +1 more source
Remodeling of macular vortex veins in pachychoroid neovasculopathy. [PDF]
AbstractSuperior and inferior macular vortex veins are divided by a horizontal watershed passing through the macula. We evaluated macular vortex vein remodeling in eyes with pachychoroid neovasculopathy (PNV). Thirty eyes of 30 patients with treatment-naïve PNV and 30 normal eyes of 30 age-, gender-, and refraction-matched subjects were studied.
Matsumoto H +3 more
europepmc +4 more sources
Importance of fluorescein angiography as a predictor of treatment response in patients with pachychoroid neovasculopathy. [PDF]
The purpose of this study was to evaluate the treatment outcomes of patients with pachychoroid neovasculopathy (PNV) who received photodynamic therapy (PDT) combined with intravitreal anti-vascular endothelial growth factor (VEGF) agents, with a particular focus on the fluorescein angiography (FA) findings.
Maruyama-Inoue M +4 more
europepmc +4 more sources

